Q

Mainz Biomed NV
D

QUCY

0.49780
USD
-0.03
(-5.54%)
مغلق
حجم التداول
72,341
الربح لكل سهم
-0
العائد الربحي
-
P/E
-0
حجم السوق
6,230,134
المقالات
المزيد

العنوان: Mainz Biomed NV

القطاع: Healthcare
الصناعة: Diagnostics & Research
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.